“I think the Republican candidate is very good and I think she should win, because the Democrat candidate’s a disaster,” Trump told reporters Sunday on Air Force One, without naming either Earle-Sears ...

An FDA advisory panel has recommended approval of Moderna’s mRNA-based flu vaccine, mFlusiva, for adults ages 50-64, and adults 65 and older if a specific condition is met. The vaccine was about 27% ...

Although not bound by the panel's recommendations, the FDA takes them into consideration when reviewing the Biologics License Application. The Food and Drug Administration’s (FDA) Vaccines and Related ...

It is easy to forget to clean the things we use to clean. The washing machine, vacuum cleaner, and dishwasher are household appliances we rely on to keep our homes clean, but they are often overlooked ...

WASHINGTON (AP) — A new kind of flu vaccine moved a step closer to the U.S. market Thursday as federal health advisers recommended approval of the first made with the same mRNA technology that was key ...

WASHINGTON — A new kind of flu vaccine moved a step closer to the U.S. market Thursday as federal health advisers recommended approval of the first made with the same mRNA technology that was key to ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

An FDA advisory panel voted 8-0, with one abstention, to recommend updating COVID-19 vaccines for the 2026-27 season to target the dominant XFG variant, despite concerns from some members about ...

The FDA’s Vaccines and Related Biological Products Advisory Committee has voted to recommend updating this fall’s Covid-19 vaccines to target the XFG variant, a fast-spreading omicron hybrid strain ...

The FDA's vaccine advisors voted 8 to 0, with one abstention, in favor of a monovalent XFG vaccine for COVID-19 shots for the 2026-2027 season. The Vaccines and Related Biological Products Advisory ...

Long-acting once-weekly growth hormone treatment has moved closer to expanded use in Europe for two new pediatric indications, potentially reducing injection frequency for children with specific ...